| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/21/2004 | US20040209325 Comprises expression vectors coding nucleotide sequences for transformation and generation of plants with enhanced freeze, disease, drought and salt resistance |
| 10/21/2004 | US20040209323 Protein expression by codon harmonization and translational attenuation |
| 10/21/2004 | US20040209322 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold |
| 10/21/2004 | US20040209321 Methods of in vitro protein synthesis |
| 10/21/2004 | US20040209318 Reagents and methods for the detection and quantification of vancomycin in bilogical fluids |
| 10/21/2004 | US20040209313 T2R receptor binding assays that identify potential bitter taste modulatory compounds |
| 10/21/2004 | US20040209310 Ligands that bind to the amyloid-beta precursor peptide and related molecules and uses thereof |
| 10/21/2004 | US20040209308 Methods of assaying receptor activity and constructs useful in such methods |
| 10/21/2004 | US20040209306 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 10/21/2004 | US20040209305 Epoxide polymer surfaces |
| 10/21/2004 | US20040209301 DNA chip having multi-layer film structure |
| 10/21/2004 | US20040209299 In vitro DNA immortalization and whole genome amplification using libraries generated from randomly fragmented DNA |
| 10/21/2004 | US20040209298 Preparing nucleotide sequences for use in generation of genomic and complimentary DNA libraries; genomics; genotyping and gene expression profiling; high throughput assay |
| 10/21/2004 | US20040209297 Novel human kinases and polynucleotides encoding the same |
| 10/21/2004 | US20040209296 Using transcription factor inhibitors and human leukocyte antigen antibodies to prevent and treatcell proliferfative disorders; genetic vaccines and antitumor agents |
| 10/21/2004 | US20040209295 Chimeric MHC protein and oligomer thereof |
| 10/21/2004 | US20040209288 Using adjustments in leukotriene biosynthetic profile as tool to diagnosis and treat cardiovasular disorders |
| 10/21/2004 | US20040209286 Comprises nucleotide sequences coding g protein coupled receptors for use in identifying modulators of sweet taste transduction; food processing; improving palatability of low-calorie beverages through the development of new artificial sweeteners |
| 10/21/2004 | US20040209280 Method for sequencing nucleic acids by observing the uptake of nucleotides modified with bulky groups |
| 10/21/2004 | US20040209279 Comprises regulatory nucleotide sequences for generating animal model for liver disorders |
| 10/21/2004 | US20040209278 Detection of modular polyketide synthase gene clusters |
| 10/21/2004 | US20040209276 Heat resistant polymerases for use in propagation and replication of nucleic acids |
| 10/21/2004 | US20040209274 Constructs for Gene Expression Analysis |
| 10/21/2004 | US20040209273 Plant stress-regulated genes |
| 10/21/2004 | US20040209272 Orientation-directed construction of plasmids |
| 10/21/2004 | US20040209271 Dna providing system |
| 10/21/2004 | US20040209270 Screening microorganism for ability to produce erythromycins for treatment of tumors and fungal infection; biosensors and macrolides |
| 10/21/2004 | US20040209269 Method of functionalising solid supports |
| 10/21/2004 | US20040209268 Process for constructing mutant |
| 10/21/2004 | US20040209264 Comprises nucleotide sequences coding daugther of legless protein for use in identifying modulator for tissue regeneration and repair and the treatment of blood disorders |
| 10/21/2004 | US20040209263 Selection of catalytic nucleic acids targeted to infectious agents |
| 10/21/2004 | US20040209258 Methods and devices for removal of organic molecules from biological mixtures using an anion exchange material that includes a polyoxyalkylene |
| 10/21/2004 | US20040209256 Transforming microorganisms with expression vector comprising hydrogenase sequences for use in generating hydrogen producing microbes |
| 10/21/2004 | US20040209252 Electroactive complex, electroactive probe and preparation method |
| 10/21/2004 | US20040209251 Using collision-induced dissociation mass spectrometry (MS) to determine sequence of oligomers |
| 10/21/2004 | US20040209249 Using protein crystalization to identify and characterize three dimensional structure of microbial heat resistant protein; rational protein design |
| 10/21/2004 | US20040209248 Comprises modified viral surface protein for use in detection and diagnosis of hepatitis infection |
| 10/21/2004 | US20040209247 Viral vector comprising E1 region for use as gene transfer tool in genetic engineering |
| 10/21/2004 | US20040209245 Production of pseudotyped recombinant AAV virions |
| 10/21/2004 | US20040209244 Anti-dengue virus antibodies, compositions, methods and uses |
| 10/21/2004 | US20040209243 Kunitz domain library |
| 10/21/2004 | US20040209240 Anti-neoplastic viruses |
| 10/21/2004 | US20040209239 Methods and compositions fir identifying episomal dna virus infection treatment |
| 10/21/2004 | US20040209238 Transgenic cells expressing preferential fusion proteins dynamically visualized through chronological photographing of dividing via fluorescence/laser microscopy |
| 10/21/2004 | US20040208920 injectable liposomal composition for delivery of large amounts of water-soluble substance comprises a plurality of liposomal vesicles having a high weight ratio of lipid to encapsulated water-soluble substance which is distributed over the liposomal vesicles; high efficiency of encapsulation |
| 10/21/2004 | US20040208907 using toxin complex (TC) proteins obtainable from Xenorhabdus, Photorhabdus, and Paenibacillus to control insects; transgenic plant or plant cell with the proteins |
| 10/21/2004 | US20040208905 Gene delivery of a viral vector |
| 10/21/2004 | US20040208900 mutant rabies virus comprising a rabies virus N protein that is not phosphorylated; central nervous system (CNS) |
| 10/21/2004 | US20040208897 microbial cell comprising an Environmentally Limited Viability System made of an essential and a lethal gene ; cell is viable in a permissive environment and non-viable or temporarily viable in a non-permissive environment |
| 10/21/2004 | US20040208895 administering HETEROLOGOUS GENE PRODUCTS IN HOST CELL SYSTEMS AND/OR TO RESCUE NEGATIVE STRAND RNA RECOMBINANT VIRUSES |
| 10/21/2004 | US20040208890 secreted Chlamydia polypeptides expressed by a Gram-negative bacterial strain and secreted by the type III secretion pathway; vaccination, and diagnostic uses |
| 10/21/2004 | US20040208889 Pharmaceutical use for secreted bacterial effector proteins |
| 10/21/2004 | US20040208888 Method of and compositions for immunization with the pseudomonas v antigen |
| 10/21/2004 | US20040208881 B1k chain of laminin and methods of use |
| 10/21/2004 | US20040208878 Treatment of acute lung injury, fibrosis and metastasis with antagonists of alphabetav6 |
| 10/21/2004 | US20040208867 Mutant protein with amino acid sequence that is substituted, deleted, inserted or transposed; 3'-phosphoadenosine5'-phosphosulfate; gene expression; medical diagnosis |
| 10/21/2004 | US20040208857 Producing a donor-specific immunotolerance against transplanted tissue by administering embryonic stem cell-like cell lines (ECL) obtained from blastocysts and are transfected with genetic material of the donor, which codes for the major histocompatibility complex (MHC) haplotypes |
| 10/21/2004 | US20040208856 Oligonucleotides targeted to nucleic acid encoding apolipoprotein C-III; gene expression inhibition; medical diagnosis |
| 10/21/2004 | US20040208851 Immunization by inoculation of DNA transcription unit |
| 10/21/2004 | US20040208850 Antitumor agents; enhanced by administration of cytoxic T lymphocyte (CTLA-4) blocker and/or cytosine-guanosine (CpG) oligodeoxynucleotide immunomodulators |
| 10/21/2004 | US20040208849 Reducing viability of tumor cell by administering virus that is not a common human pathogen such as a Rhabdovirus, a picomavirus, and preferably is vesicular stomatitis virus (VSV) |
| 10/21/2004 | US20040208848 Contains multiplicity of expressible coding sequences derived from the neoplastic cell, pathogen or parasite, and gene expression of coding sequences in a human or animal; immunogens for vaccines; antitumor and anticarcinogenic agents; viral replicon selected nucleic acid expression libraries |
| 10/21/2004 | US20040208847 Administering to mammal a vector particle exhibiting an adeno-associated virus-4 (AAV-4) capsid protein; vision defects |
| 10/21/2004 | US20040208846 Mini-Ad vector for immunization |
| 10/21/2004 | DE10316109A1 Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae A process for the fermentative preparation of L-amino acids using strains of the family Enterobacteriaceae |
| 10/21/2004 | DE10315760A1 L-Carnitin Dehydrogenasen, deren Derivate und ein Verfahren zur Herstellung von substituierten (S)-Alkanolen L-carnitine dehydrogenases, their derivatives and to a process for the preparation of substituted (S) -alkanols |
| 10/21/2004 | CA2522056A1 Chalcone synthase dihydroflavonol 4-reductase and leucoanthocyanidine reductase from clover, medic ryegrass or fescue |
| 10/21/2004 | CA2521729A1 Methods and means for increasing the tolerance of plants to stress conditions |
| 10/21/2004 | CA2521614A1 Method of determining xenograft responses |
| 10/21/2004 | CA2521469A1 Identification of novel nogo-receptors and methods related thereto |
| 10/21/2004 | CA2521402A1 Pectate lyases, nucleic acids encoding them and methods for making and using them |
| 10/21/2004 | CA2521378A1 .delta.-4 desaturases from euglena gracilis, expressing plants, and oils containing pufa |
| 10/21/2004 | CA2521288A1 L-carnitin dehydrogenases, their derivatives and method for producing substituted (s) alkanols |
| 10/21/2004 | CA2521273A1 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production |
| 10/21/2004 | CA2521127A1 Polymerase inhibitor and method of using same |
| 10/21/2004 | CA2520987A1 Targets for tumor growth inhibition |
| 10/21/2004 | CA2520866A1 Phosphodiesterase 2a and methods of use |
| 10/21/2004 | CA2520028A1 Compounds and methods to enhance raav transduction |
| 10/21/2004 | CA2520016A1 Pharmico-gene therapy of epithelial sodium channel associated disorders |
| 10/21/2004 | CA2488224A1 Irna conjugates |
| 10/20/2004 | EP1469316A1 Screening method |
| 10/20/2004 | EP1469308A1 Method of screening drug |
| 10/20/2004 | EP1469084A2 Polymorphisms in the human KDR gene |
| 10/20/2004 | EP1469079A1 Carbonly reductases, polynucleotides comprising DNA encoding the same, methods for producing the same,and methods for producing optically active alcohol utilizing the same |
| 10/20/2004 | EP1469078A1 Method for preparing Sporodiobolus strains with an improved coenzyme Q10 production |
| 10/20/2004 | EP1469077A1 Cell-specific expression/replication vector |
| 10/20/2004 | EP1469076A2 Recombinant PRRS proteins, diagnostic kits and vaccines containing said recombinant proteins |
| 10/20/2004 | EP1469075A1 Gene-therapy for solid tumors, papillomas and warts |
| 10/20/2004 | EP1469074A1 Human calcium channel compositions and methods |
| 10/20/2004 | EP1469073A2 Polynucleotides and membrane-bound polypeptides encoded thereby |
| 10/20/2004 | EP1469072A2 Means and methods for diagnosing and treating affective disorders |
| 10/20/2004 | EP1469071A1 Method of screening drug for improving insulin resistance |
| 10/20/2004 | EP1469070A1 Livin-specific siRNAs for the treatment of therapy-resistant tumors |
| 10/20/2004 | EP1469069A1 Method for forming full-lenght cDNA libraries |
| 10/20/2004 | EP1469068A1 Apparatus for separating and purifying nucleid acid and method for separating and purifying nucleid acid |
| 10/20/2004 | EP1469067A1 Method and apparatus for detecting nucleic acid data |
| 10/20/2004 | EP1469010A1 Transcription regulatory gene and peptide |
| 10/20/2004 | EP1469009A2 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 10/20/2004 | EP1468698A2 Human quinone reductase 2 conjugates for adept and gdept |
| 10/20/2004 | EP1468695A1 Methods and compositions useful for inhibition of angiogenesis |